Yet thanks to a new hospital-based educational and advocacy initiative for COPD patients, Croswell has been managing well at ...

While COPD (chronic obstructive pulmonary disease) symptoms may start out as mild to moderate — with episodes of difficulty breathing that come and go — over time, COPD tends to get worse ...

Many people with COPD can control their symptoms by using inhaled medicines each day. But inhaled medicines may not offer enough relief for people who also have high levels of a type of white ...

Chronic obstructive pulmonary disease (COPD) is a lung condition which is caused by damage to the lungs. This damage results ...

COPD headaches may be related to chronic inflammation, oxidative stress, or a buildup of carbon dioxide in your blood. Treatment can involve oxygen therapy and medications like bronchodilators and ...

In a recent paper, researchers recommended prompt screening methods and management strategies for comorbidities that occur commonly in patients with COPD.

A new study published in the Journal of the COPD Foundation showed that perceived stress significantly worsens respiratory ...

Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...

For some patients with chronic obstructive pulmonary disease (COPD), summer can be one of the most stressful times of the year. Not only is allergy season in full swing, but rising temperatures ...

The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult ...

The US Food and Drug Administration (FDA) has approved mepolizumab as a maintenance treatment for chronic obstructive ...